After the Ablation: StimCardio, Wearable Neuromodulation and the Next AF Outcome Gap
Dr. Dereck Mush, MD, MBA
What they do
The company develops implantable, rechargeable sacral neuromodulation devices that deliver mild electrical stimulation to pelvic nerves. These systems are purchased by urology and gynecology clinics to treat overactive bladder and fecal incontinence.
The record
- Vertical
- Medical Devices
- Sub-segment
- Neuromodulation
- Product type
- Device
- Stage
- Public
- Headquarters
- Irvine, USA
- Region
- North America
- Founded
- 2013
- Total funding
- $114M raised
Notable investors: Andera Partners, NeoMed Management, Legend Capital.
Also in Medical Devices
Related on The Signal
Dr. Dereck Mush, MD, MBA
Next-Gen Neurotechnologies: Graphene Electrodes and Magnetic Surgical Robotics in Deep Brain Neuromodulation
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The 8 Most Innovative MedTech Devices Right Now
From a pacemaker the size of a vitamin to a scanner that books its own follow-up, these are the devices actually changing care in 2026.
Dr. Dereck Mush, MD, MBA